VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $245,150 | +87453.6% | 9,110 | -2.1% | 0.28% | +26.4% |
| Q2 2023 | $280 | -6.4% | 9,310 | +7.5% | 0.22% | -2.2% |
| Q1 2023 | $299 | +20.6% | 8,657 | 0.0% | 0.22% | +21.0% |
| Q4 2022 | $248 | -99.9% | 8,657 | -3.3% | 0.19% | +8.1% |
| Q3 2022 | $216,000 | -15.3% | 8,957 | -3.8% | 0.17% | -9.0% |
| Q2 2022 | $255,000 | -29.8% | 9,312 | -1.7% | 0.19% | -12.5% |
| Q1 2022 | $363,000 | +21.8% | 9,472 | +1.8% | 0.22% | +33.3% |
| Q4 2021 | $298,000 | +2.1% | 9,307 | -6.1% | 0.16% | -5.3% |
| Q3 2021 | $292,000 | -13.6% | 9,907 | -0.4% | 0.17% | -13.2% |
| Q2 2021 | $338,000 | +3.7% | 9,944 | -0.8% | 0.20% | -5.7% |
| Q1 2021 | $326,000 | -7.1% | 10,020 | +2.8% | 0.21% | -18.0% |
| Q4 2020 | $351,000 | -8.1% | 9,745 | 0.0% | 0.26% | -16.9% |
| Q3 2020 | $382,000 | +7.0% | 9,745 | 0.0% | 0.31% | -5.5% |
| Q2 2020 | $357,000 | – | 9,745 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |